Pemphigoid without mucosal involvement showing autoantibodies against laminin-332 γ2 subunit

British Journal of Dermatology

Volumn 163, Issue 5, 2010, Pages 1120-1122

  Endo, Y ^a   Kato, M ^a   Kitoh, A ^a   Kore Eda, S ^a   Fukuda, S ^b   Hashimoto, T ^b   Toda, K ^c   Miyachi, Y ^a   Utani, A ^a,d  

^a KYOTO UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kitano Hospital   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

Laminin 332; Pemphigoid

Indexed keywords

AUTOANTIBODY; BETAMETHASONE; BULLOUS PEMPHIGOID ANTIGEN 1; COMPLEMENT COMPONENT C3; DAPSONE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LAMININ 332 GAMMA2 SUBUNIT AUTOANTIBODY; UNCLASSIFIED DRUG;

ADULT; BLISTER; CASE REPORT; CORTICOSTEROID THERAPY; EOSINOPHIL; ERYTHEMA; FOREARM; HEALING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LETTER; LIMB; MALE; NEUTROPHIL CHEMOTAXIS; PEMPHIGOID; PRIORITY JOURNAL; PRURITUS; TRUNK;

ANTI-INFLAMMATORY AGENTS; AUTOANTIBODIES; BETAMETHASONE; CELL ADHESION MOLECULES; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; TREATMENT OUTCOME;

EID: 78249237206     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09922.x     Document Type: Letter

References (9)

1. Bruch-Gerharz D, Hertl M, Ruzicka T,. Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapy. Eur J Dermatol 2007; 17: 191 -200.
2. Dainichi T, Takeshita H, Moroi Y, et al. Cicatricial pemphigoid with autoantibodies against the laminin 5 gamma 2 subunit. Eur J Dermatol 2005; 15: 189 -93.
3. Egan CA, Yancey KB,. The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease. Eur J Dermatol 2000; 10: 585 -9.
4. Mitsuya J, Hara H, Ito K, et al. Metastatic ovarian carcinoma-associated subepidermal blistering disease with autoantibodies to both the p200 dermal antigen and the gamma 2 subunit of laminin 5 showing unusual clinical features. Br J Dermatol 2008; 158: 1354 -7.
5. Nousari HC, Rencic A, Hsu R, et al. Anti-epiligrin cicatricial pemphigoid with antibodies against the gamma 2 subunit of laminin 5. Arch Dermatol 1999; 135: 173 -6.
6. Tsuruta K, Takazawa Y, Kido K, et al. A case of mucous membrane pemphigoid with autoantibodies against the gamma 2 chain of laminin 5. Jpn J Dermatol 2009; 119: 1979 -84.
7. Fujimoto W, Toi Y, Okazaki F, et al. Anti-epiligrin cicatricial pemphigoid with IgG autoantibodies to the beta and gamma subunits of laminin 5. J Am Acad Dermatol 1999; 40: 637 -9.
8. Sadler E, Lazarova Z, Sarasombath P, et al. A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer. J Dermatol Sci 2007; 47: 1 -7.
9. Fairley JA, Woodley DT, Chen M, et al. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading. J Am Acad Dermatol 2004; 51: 118 -22.